Resources for Researchers
Learn more about Research Resources
Intramural Funding Opportunities
Deadline: August 17
UCSF Prostate Cancer Program 2018 Pilot Research Funding Awards [Application]
The UCSF Prostate Cancer Program seeks to fund pilot projects in prostate cancer research to be undertaken at UCSF or at collaborating UC campuses. Funds are available to support three proposals.
Deadline: July 25Astellas Oncology C3 Prize Innovation Challenge
Astellas is inviting patients, caregivers, healthcare professionals and concerned citizens who want to improve cancer care to propose ideas that address specific challenges encountered in low- and middle-income countries within the following three categories: support tools, educational tools and technology.
Deadline: July 31
The Mark Foundation for Cancer Research ASPIRE Awards
The ASPIRE Awards are designed to enable innovative approaches to solving high-impact problems in cancer research that tend to fall outside the scope of other funding opportunities. These awards will be used to support high-risk, high-reward projects with research plans designed to answer key feasibility and proof-of-concept in an accelerated timeframe, typically one year.
Deadline: August 6
Beckman Young Investigator Program
Provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences, particularly to foster the invention of methods, instruments and materials that will open up new avenues of research in science.
Preliminary submission deadline: September 6
CRUK Brain Tumour Awards
Supports multidisciplinary approaches to tackle key basic and translational questions in brain tumour research. We’re providing up to up to £10m per award over five years to support the boldest and most innovative projects to drive impact for patients.
Deadline: September 6
Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Africa
- LOI due July 17: Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R21 Clinical Trial Not Allowed)
- LOI due July 17: Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)
- Due July 25: Administrative Supplements to Support Acquisition and Annotation of Biospecimens from Racial/Ethnically Diverse Cancer Patients for the Development of Models for the Human Cancer Models Initiative (HCMI) (NOT-CA-18-076)
To view all NCI funding opportunities, search here